The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Björklund, Natalie K ^a   Evans, Jane A ^a   Greenberg, Cheryl R ^a   Seargeant, Lorne E ^a   Schneider, Carol E ^a   Chodirker, Bernard N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA FETOPROTEIN;

ARTICLE; CANADA; CONTROLLED STUDY; DATA ANALYSIS; EXPERIENCE; FEMALE; GENE FREQUENCY; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; OUTCOMES RESEARCH; POPULATION RESEARCH; PREGNANCY COMPLICATION; PROTEIN VARIANT; QUESTIONNAIRE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

EID: 18144386249     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-2-65     Document Type: Article

References (33)

1. Ross HL, Elias S: Maternal serum screening for fetal genetic disorders. Obstet Gynecol Clin North Am 1997, 24: 33-47.
2. van Rijn M, van der Schouw YT, Hagenaars AM, Visser GH, Christiaens GC: Adverse obstetric outcome in low-and high-risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol 1999, 94:929-934.
3. Eskes TK: Homocysteine and human reproduction. Clin Exp Obstet Gynecol 2000, 27:157-167.
4. Eskes TK: Clotting disorders and placental abruption: homocysteine-a new risk factor. Eur J Obstet Gynecol Reprod Biol 2001, 95:206-212.
5. Raijmakers MT, Zusterzeel PL, Roes EM, Steegers EA, Mulder TP, Peters WH: Oxidized and free whole blood thiols in preeclampsia. Obstet Gynecol 2001, 97:272-276.
6. Ferguson SE, Smith GN, Walker MC: Maternal plasma homocysteine levels in women with preterm premature rupture of membranes. Med Hypotheses 2001, 56:85-90.
7. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM: Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000, 71:962-968.
8. Powers RW, Dunbar MS, Gallaher MJ, Roberts JM: The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol 2003, 101:762-766.
9. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA: Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002, 87:779-785.
10. Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, Gauthier R, Feoli-Fonseca JC: Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002, 347:19-25.
11. Björklund NK, Evans JA, Greenberg CR: Association of thermolabile methylenetetrahydrofolate reductase (C677T) with elevated maternal serum alpha fetoprotein. [Abstract]. Am J Hum Genet 2000, 67:417.
12. Mogk RL, Rothenmund H, Evans JA, Carson N, Dawson AJ: The frequency of the C677T substitution in the methylenetetrahydrofolate reductase gene in Manitoba. Clin Genet 2000, 58:406-408.
13. Angus VC, Entwistle VA, Emslie MJ, Walker KA, Andrew JE: The requirement for prior consent to participate on survey response rates: a population-based survey in Grampian. BMC Health Serv Res 2003, 3:21.
14. Fowler FJ Jr, Gallagher PM, Stringfellow VL, Zaslavsky AM, Thompson JW, Cleary PD: Using telephone interviews to reduce nonresponse bias to mail surveys of health plan members. Med Care 2002, 40:190-200.
15. International Classification of Diseases, 9th revision, Clinical Modification. 4th edition. Utah: Medicode Publications; 1994.
16. Björklund NK, Evans JA, Greenberg CR: Folic acid supplementation: more work is needed. CMAJ 2000, 163: 1129-1130.
17. Health Canada: Primary Prevention of Neural Tube Defects with Folic Acid. [Electronic Citation]. Edited by: Health Canada. Government of Canada; 2003.
18. Shipchandler MT, Moore EG: Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995, 41:991-994.
19. Wilson DH, Herrmann R, Hsu S, Biegalski T, Sohn L, Forsythe C, Novotny M, Beggs M, Manderino G: Ion capture assay for folate with the Abbott IMx analyzer. Clin Chem 1995, 41:1780-1781.
20. Greenberg CR, Hamerton JL, Nigli M, Wrogemann K: DNA studies in a family with Duchenne muscular dystrophy and a deletion at Xp21. Am J Hum Genet 1987, 41:128-137.
21. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK: Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002, 107: 162-168.
22. NCSS Statistical Systems for Windows. Kaysville, Utah: Dr. Jerry L Hintze 2001.
23. Chango A, Potier DC, Boisson F, Guilland JC, Barbe F, Perrin MO, Christides JP, Rabhi K, Pfister M, Galan P, Hercberg S, Nicolas JP: 5, 10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr 2000, 84:891-896.
24. Pagan K, Hou J, Goldenberg RL, Cliver SP, Tamura T: Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy. Clin Chim Acta 2001, 306:103-109.
25. Chodirker BN, Erdile LB, MacDonald KM, Harman CR, Cheang MS, Evans JA: MSAFP levels in aboriginal Canadian women. Can J Public Health 1994, 85:424-426.
26. Population by ethnic origin, 1996 Census, provinces and territories. [Electronic Citation]. Statistics Canada 2003.
27. Infante-Rivard C, Rivard GE, Gauthier R, Theoret Y: Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 2003, 49:1476-1482.
28. Castro LC, Avina RL: Maternal obesity and pregnancy outcomes. Curr Opin Obstet Gynecol 2002, 14:601-606.
29. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JI, Kostense PJ, Aarnoudse JG, Dekker GA: Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001, 184:394-402.
30. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP, Mares P: Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999, 81: 891-899.
31. Zusterzeel PL, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA: Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens Pregnancy 2000, 19:299-307.
32. House JD, March SB, Ratnam S, Ives E, Brosnan JT, Friel JK: Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit. CMAJ 2000, 162:1557-1559.
33. D'Anna R, Baviera G, Corrado F, Ientile R, Granese D, Stella NC: Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand 2004, 83:155-158.